FDA panel gives nod to six controversial peptides

The market for peptides, chemicals that have been increasingly promoted as new medical treatments and wellness products, got a big boost this week as a divided Food and Drug Administration panel voted on Thursday and Friday to recommend loosening regulations on six peptide treatments. The Pharmacy...

Redirecting to full article...